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INTRODUCTION                                                                       
Urinary tract is the second most common site of bacterial 
infections in humans.
1
 The prevalence of Urinary tract 
infection (UTI) depends on age, sex, race and predisposing 
factors.
2
 Predisposing factors in the development of UTI 
are anatomical, physiological, infective, social and 
environmental.
1,3
 UTI occurs in any age and in sex.
4
 
Mostly it is common in women than men. Female to male 
ratio is 4.6:1.
5
  
Bacteria responsible for UTI, often originate from the 
faecal and perineal  flora.
6,7
 UTIs are almost always caused 
by bacteria, although some viruses, fungi and parasites can 
infect the urinary tract as well. More than 85% of UTIs are 
caused by bacteria. Escherichia coli is the commonest 
cause of UTI followed by Klebsiella species, P. mirabilis, 
A. anitratus, Enterococcus faecalis, coagulase negative 
Staphylococcus, Streptococcus species.
1,8,9 
 
Under normal circumstances, these bacteria are cleared 
from the urinary system by effective protective 
mechanisms. If, however, they over come these 
mechanisms, subsequent progress is determined by host 
susceptibility and bacterial virulence factors.
7
 A significant 
factor for the pathogenesis of UTI is bacterial adhesion.
10, 
11
 Uropathogens achieve adherence to mucosal surface of 
urinary tract by fimbrial and non-fimbrial adhesions.
9
 
According to hemagglutination (HA) patterns bacterial 
adhesions have been classified into two types, i.e., 
mannose sensitive hemagglutination (MSHA) and 
mannose resistant hemagglutination (MRHA).
12
  
Bacteriological examination of the urine is the major aid to 
the diagnosis of infections. Culture technique is employed 
to detect bacteria in urine.
13
 The organisms are identified 
and their susceptibility to antimicrobial agents is 
determined.
14
 Adherence assay is done by HA test and 
Giemsa staining technique.
15,16
 Detection of hemolysin 
production is done on 5% washed sheep blood agar.
17,18
 
Motility test is done by stabbing the isolates into SIM 
biochemical media.
17
 
MATERIALS AND METHODS 
This is prospective study conducted in Department of 
Microbiology, Yuvaraja’s College (Autonomous), 
University of Mysore, Mysore, India; from December 
2010 to November 2012. Urine specimens obtained from 
adult patients (above 18 years) attending to K.R. hospital 
and Mission Hospital Mysore, clinically diagnosed as UTI 
and submitted to Microbiology Department of Clinical 
Laboratory Service (CLS) for bacteriological culture and 
sensitivity constitute the subject for study. Informed 
consent was taken from each subject included in the study. 
For this study, the inclusion criteria were dysuria, fever 
due to UTI, frequency, painful micturation and exclusion 
criteria were malignancy, diabetes, tuberculosis, metabolic 
disorder, subject on antibiotic treatment, dialysis, HIV 
seropositive on ART and catheterized urine specimen. 
Microscopic study was done for each specimen. The 
microscopic findings e.g., pus cells, erythrocytes, epithelial 
cells, casts and crystals were recorded.
19,20
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Urine culture of the un-centrifuged urine was done by 
semi-quantitative method using standard wire loop. 
Sterilized inoculation loop was dipped in urine pot at 90, 
a loopful of urine holding 0.001 ml was taken. It was 
inoculated on cystein lactose electrolytes deficient agar 
(CLED) media, 5% sheep blood agar and MacConkey agar 
respectively. The inoculated plates were incubated 
aerobically in bacteriological incubator set at 37C for 24-
48 h.
21,22
 Identification was done on the basis of colony 
morphology, grams stain, catalase test, oxidase test and 
standard biochemical tests that include triple sugar iron 
agar (TSI) media, Simmons’ citrate agar media, sulphide 
indole motility (SIM) media, and Christensens’ urease 
medium .
23
 
Antibiotic sensitivity test (AST)
 
It was done by Kirby-Bauer disk diffusion test method on 
Muller-Hinton agar (MHA) plate and interpreted according 
to CLSI guidelines. Escherichia coli ATCC 25922 were 
used as control and tested along with the test strains daily 
as described for Enterobacteriaceae.
14 
Adherence assay  
Adherence assay was done by HA test
16, 17, 24 
and Giemsa 
staining technique. 
A) Hemagglutination (HA) test 
It was done by Slide agglutination method and microtiter 
plate agglutination method. 
a) Slide agglutination method 
Eight glass slide (3×1 inch) was taken and bacterial isolate 
number on each glass slide plus human (H), sheep (S), 
rabbit (Rb), rat (Ra) in first 4 slide respectively; similarly 
H+, S+, Rb+, Ra+  in next 4 slide respectively for red 
blood cell suspension with 1% mannose were marked. For 
each slide 50 µl of PBS with pH 7.2 was added; bacterial 
colony was taken from 5% sheep blood agar plate and 
emulsion was made on each glass slide. A total of 50 µl of 
4% red cell suspension with 1% mannose and without 
mannose of all 4 species was added on respective marked 
slide with bacterial milky white emulsion (approximately 
1×10
9 
bacteria/ml); then mixed with sterilized wooden 
tooth pick separately on each glass slide. The slide was 
rotated for 1 minute.
16
 Hemagglutination was observed, 
initially macroscopically and then microscopically using 
10× objective and interpreted as +1, +2, +3 according to 
agglutination pattern. The results were recorded. 
b) Microtiter hemagglutination method 
With the help of sterilized inoculation loop, from bacterial 
stock vial subculture was done in BHI broth (3-5 ml) and 
incubated aerobically for 4 h at 37C in bacteriological 
incubator.
1
 Following incubation, subculture was done in 
10 ml Brain Heart Infusion (BHI) broth in McCartney 
bottle and incubated statically aerobically overnight at 
37C in bacteriological incubator.25 In test tube rack 16 
clean, sterilized (25 ml) test tubes were kept and marked 1-
16 respectively. Each tube was filled with 9 ml PBS; pH 
7.2. Using 1 ml delivering micropipette, the overnight 
bacterial broth in McCartney bottle was taken in and out 3-
4 times, then 1 ml broth was pipetted out, any excess drop 
was removed with tissue paper from outside of the tips. 
Carefully the broth in pipette was delivered into the tube 
number 1, by touching the wall of tube but not dipping into 
the diluents. With fresh sterile tips, the first dilution was 
done by filling in and out 3-4 times, and then 1 ml 
suspension was transferred to next tube (tube number 2). 
In the same way remaining dilutions were done. Surface 
viable count was done by Miles and Misra method.
26
 Using 
20 ml micropipette, from each tube 20 µl suspension was 
allowed to fall from a height 2.5 cm on a well dried 
nutrient agar plate in duplicate, where it spreads over 1.5-2 
cm in diameter.  
The plates were incubated aerobically over night at 37C. 
Colony without confluence was counted and calculated 
bacteria per ml using formula: Bacteria per ml in BHI 
broth = Number of colony × 50. After that the broth 
culture was compared with McFarland 0.5 standards. The 
turbidity was adjusted by diluting with PBS pH 7.2. The 
tube containing 2×10
8
 bacteria per ml in PBS pH 7.2 were 
used for HA test.
27
 A 96 well micro titer plate was taken. 
For 1 bacterial isolates 8 wells were selected, number 
isolated and marked M+ and M-. 100 micro liter 4% red 
blood cells suspension of human, sheep, rabbit, and rat 
without mannose in PBS pH 7.2 and with 1% mannose in 
PBS pH 7.2 were added in respective well. Bacterial 
inoculum (100 µl) was inoculated to BHI broth (2×10
8
 
bacteria ml
-1
) in each well and mixed by shaking for 1 
minute. Well containing only the suspension of 4% 
erythrocytes were used as negative control. Using 
Parafilm, the micro titer plate was covered. A small pellet 
of erythrocytes at the bottom after 1 hour incubation at 
37C were considered negative, and those containing an 
even sheet of erythrocytes across the well were considered 
positive.
27
 Following incubation the first reading (HA) was 
recorded. Again applying parafilm microtiter plate was 
covered and kept in 4C for overnight and second reading 
was recorded. 
B) Giemsa staining 
Adherence assay of uropathogenic bacteria was done on 
buccal epithelial cells by Giemsa staining as described by 
Foresteir et al.
15
 With certain modifications for selected 
uropathogenic clinical isolates. Detection of hemolysin 
production and motility testing were done by standard 
microbiological procedure.
17
 
RESULTS 
Out of 250 test urine specimen, 150 (60%) were either 
insignificant growth or sterile and 100 (40%) culture 
positive (significant bacteriuria), 98% were monomicrobial 
and 2% were polymicrobial (Table-1). The 100% of 
control specimen were either insignificant growth or 
sterile. Out of 102 isolates 95 (93.13%) were gram 
negative bacteria and 7 (6.87%) gram positive bacteria. 
(Table 1, 2 & 3). 
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Table 1: Distribution of organisms isolated in UTI patients 
Bacteria IP* 
n = 125 (%) 
OPD** 
n = 125 (%) 
Total 
n = 250 
Escherichia coli 30 (48.4) 22 (55) 52 (51) 
Klebsiella pneumonia 10 (16.12) 6 (15) 16 (15.7) 
Acinetobacter anitratus 6 (9.7) 5 (12.5) 11 (10.8) 
Enterobacter species 3 (4.83) 2 (5) 5 (4.9) 
Proteus species 3 (4.83) 3 (7.5) 6 (5.9) 
Citrobacter species 2 (3.22) -- 2 (1.96) 
Pseudomonas aeruginosa 2 (3.22) -- 2 (1.96) 
Morganella morgani 1 (1.61) -- 1 (1) 
Enterococcus species 3 (4.83) 1 (2.5) 4 (3.9) 
Staphylococcus aureus 2 (3.22) 1 (2.5) 3 (2.94) 
Total 62 (49.6%) 40 (32%) 102 (100%) 
* IP: inpatient; **OPD: outpatient department 
Table 2: Incidence of UTI in age group divided in 10 year interval 
Age (year) Significant bacteriuria (%) Sterile (culture negative) (%) Total (%) 
18-27 17 (32) 36 (68) 53 (21.2) 
28-37 13 (27) 35 (73) 48 (19.2) 
38-47 12 (41.4) 17 (58.6) 29 (11.6) 
48-57 16 (47) 18 (53) 34 (13.6) 
58-67 15 (50) 15 (50) 30 (12) 
68-77 12 (40) 18 (60) 30 (12) 
78-87 15 (57.7) 11 (42.3) 26 (10.4) 
Total 100(40%) 150(60%) 250 (100%) 
 
Table 3: Antimicrobial resistance pattern 
Bacteria (No.) A 
(%) 
Ak 
(%) 
Ce 
(%) 
Ci 
(%) 
Cf 
(%) 
Co 
(%) 
Na 
(%) 
Nf 
(%) 
Nx 
(%) 
Escherichia coli  (n=52) 100 17.3 47 52 63.5 85 80.8 21.2 71.2 
Klebsiella pneumoniae (n=16) 100 12.5 75 75 75 93.7 87.5 68.7 75 
Acinetobacter anitratus (n=11) 100 18.2 27.3 27.3 18.2 81.8 81.8 72.7 45.5 
Enterobacter species (n=5) 100 60 80 100 40 60 100 60 80 
Proteus mirabilis (n=6) 100 0 0 33.3 50 66.7 100 0 50 
Citrobacter species (n= 2) 100 50 100 100 50 100 100 100 100 
Pseudomonas aeruginosa  (n=2) 100 50 100 100 50 100 100 50 100 
Morganella morgani (n=1) 100 0 0 0 0 100 0 0 0 
Enterococcus species (n=4) 100 0 0 0 0 25 100 100 25 
Staphylococcus aureus (n=3) 100 33.3 33.3 0 33.3 33.3 100 33.3 33.3 
Total No. (n = 102) 100 19.6 47 52 54 80.4 82.4 40.2 65.7 
 
Hemagglutination properties 
There are 23 different agglutination patterns in 52 hemagglutinating uropathogens. (Table-4, 5 & 6) 
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Table 4: Distribution of hemagglutination and non-hemagglutination properties of uropathogens isolated from 
patients with various forms of UTI 
Bacteria 
Total 
No. 
Only MRHA 
No. (%) 
Only MSHA 
No. (%) 
Both MRHA and 
MSHA  No. (%) 
Non-hemagglutination 
(%) 
Escherichia coli 52 4 (12.5) 3 (9.37) 25 (78.12) 20 (38.5) 
Klebsiella pneumonia 16 1 (14.28) 4 (57.14) 2 (28.57) 9 (46.25) 
Acinetobacter anitratus 11 2 (28.57) 2 (28.57) 3 (42.85) 4 (36.4) 
Enterobacter species 5 -- 1 (50) 1 (50) 3 (60) 
Proteus species 6 -- 1 (50) 1 (50) 4 (67.7) 
Citrobacter species 2 -- -- 1 (100) 1 (50) 
Pseudomonas 
aeruginosa 
2 -- -- 1 (100) 1 (50) 
Morganella morgani 1    1 (100) 
Total (%) 95 7 (13.46) 11 (21.11) 34 (65.38) 43 (45.27) 
 
Table 5: Pattern of adherence to human buccal epithelial cells with hemagglutination property of uropathogens 
Bacteria Mean adhesion in 
only MRHA 
Mean adhesion in 
only MSHA 
Mean adhesion in 
MRHA and MSHA 
Escherichia coli 45 62 71 
Klebsiella pneumonia 40 54 60 
Acinetobacter anitratus 42 55 65 
Enterobacter species - 50 55 
Proteus species - 44 65 
Citrobacter species - - 54 
Pseudomonas aeruginosa - - 50 
 
Table 6: Distribution of hemolysin production by gram negative uropathogenic isolates 
Bacteria 
Total 
No. 
Alpha hemolysis 
(%) 
Beta hemolysis 
(%) 
Gamma hemolysis 
(%) 
Escherichia coli 52 24 (46.15) 14 (27) 14 (27) 
Klebsiella pneumonia 16 4 (25) 3 (18.75) 9 (56.25) 
Acinetobacter anitratus 11 1 (9) 5 (45.45) 5 (45.45) 
Enterobacter species 5 - 2 (40) 3 (60) 
Proteus species 6 1 (16.67) 2 (33.33) 3 (50) 
Citrobacter species 2 1 (50) 1 (50) - 
Pseudomonas aeruginosa 2 - 2 (100) - 
Morganella morgani 1 1 (100) - - 
Total 95 32 (33.7) 29 (30.5) 34 (35.8) 
 
DISCUSSION 
In present study, E. coli was the most common organism 
isolated in 51% of patient. This finding is in between result 
of study by Raco et al.
28
 (1998) (49.37%), Bonadio et al.
29
 
(2001) (54.7%), K. pneumoniae was the second most 
common organism isolated in 16% of patient. The similar 
result was seen in study by Das et al. (2006) (15.7%)
30
 and 
Neto     et al.
31
 (2003) (15%). Acinetobacter anitratus was 
the third most common organism isolated in 11% of 
patient. This result is higher than the other study.
30,31
 
Proteus mirabilis was the fourth most common organism 
isolated in 6% of patient. The similar findings was studied 
by Villar et al.
32
 (1996) (6%) and Raco et al.
28
 (1998) 
(8.86%). Pseudomonas aeruginosa was isolated 2% of 
patient. The similar finding was seen in study by Das       et 
al.
 30
 (2006)
 
(2.9%), 4 isolates of Enterococcus species 
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(3.9%) and S. aureus of 2.94%. The similar finding was 
seen in study by Das et al.
30
 (2006) (3.4%). 
Significant bacteriuria was highest 57.7% in age group 78-
87, followed by 50% in age group 58-67, 47% in age 
group 48-57, 41.4% in age group 38-47, 40% in age group 
68-77, 32% in age group 18-27 and 27% in age group 28-
37.The present results indicate that incidence of UTIs is 
more in older male patients. It might be due to prostate 
enlargement, because 42 patients included in present study 
were having BPH as an underlying condition. This result 
was supported by previous study.
33
  
Antimicrobial resistance 
The problem of bacterial antibiotic resistance emerged as 
soon as the first antibiotics became available for clinical 
use. Area-specific monitoring studies aimed to gain 
knowledge about the type of pathogens responsible for 
UTIs and their resistance patterns may help the clinician to 
choose the correct treatment.
34
 In present study, the 
antimicrobial resistance pattern of bacteria isolated from 
patients with UTI shows that 100% to ampicillin, 82.4% to 
nalidixic acid, 80.4% to cotrimoxazole, 65.7% to 
norfloxacin, 54% to ciprofloxacin, 52% to ceftriaxone, 
47% to cefotaxime, 40.2% to nitrofurantoin and 19.6% to 
amikacin. 
Most of isolated uropathogens showed multiple antibiotics 
resistance in this area. It may be due to large proportion of 
the bacterial isolate being previously exposed to several 
antibiotics. The present study data gives an idea about the 
common trend of increased antibiotics resistance of 
uropathogens in this region, which may be due to 
geographic variation or indiscriminate or sub lethal use of 
antibiotics. These results not only help in proper treatment 
of UTI patients but also discourage the indiscriminate use 
of antibiotics and prevent further development of bacterial 
drug resistance. This result will also help the clinicians to 
give proper treatment and prescription of most sensitive 
antibiotic to the patient and avoid use of resistant 
antibiotics. 
Hemagglutination properties 
In the present study, 95 gram negative uropathogenic 
bacteria have been tested for HA by using 4% RBCs 
suspension of human, sheep, rabbit and rat in absence and 
in presence of 1% mannose, 52 (54.73%) were 
hemagglutinating and 43 (45.27%) non-hemagglutinating. 
Escherichia coli and A. anitratus were maximum 
hemagglutinating 61.5% and 63.5% respectively, followed 
by Citrobacter species and   P. aeruginosa 50%, K. 
pneumoniae 43.7% and Enterobacter species 40%. There 
were 23 different agglutination patterns in 52 
hemagglutinating uropathogens. Thirty-seven (71.15%) 
hemagglutinating bacteria were both MRHA and MSHA 
of different species of erythrocytes, 10 (19.23%) were only 
MRHA of different species of erythrocytes and only 7 
(13.46%) were MSHA of different species of erythrocytes. 
Fifty-two hemagglutinating gram negative uropathogenic 
bacteria have been tested for adherence to human buccal 
epithelial cells. Adherence was higher in gram negative 
uropathogenic bacteria which give both MSHA and 
MRHA, in comparison to only MRHA or MSHA 
respectively. Maximum adherence capability was seen in 
E. coli (71/ cell) giving both MSHA and MRHA, followed 
by A. anitratus and Proteus species (65/cell), K. 
pneumoniae (60/cell), Enterobacter species (55/cell) and 
P. aeruginosa (50/cell). Similarly adherence of 
uropathogens giving only MRHA, higher adherence 
capability was seen in E. coli (62/cell), followed by A. 
anitratus (55/cell), K. pneumoniae (54/cell), Enterobacter 
species (50/cell) and Proteus species (44/cell). There was 
no only MRHA in other uropathogens. Adherence of 
uropathogens giving only MSHA, higher adherence 
capability was seen in E. coli (45/cell), followed by A. 
anitratus (42/cell) and K. pneumoniae (40/cell). There was 
no only MSHA in other uropathogens. 
The present results show that E. coli has higher adherence 
capability then other uropathogens, regardless of type of 
HA. The present study describes an     in vitro model for 
the study of bacterial adhesion, using buccal epithelial 
cells of healthy individuals and uropathogens isolated from 
patients with UTI. The results confirm that adherence of 
microorganisms to uroepithelial cells is important for the 
establishment of infections of urinary tract. In present 
study 95 gram negative uropathogenic bacteria have been 
tested for hemolysin production; 32 (33.7%) were α-
hemolytic, 29 (30.5%) were β-hemolytic and 34 (35.8%) 
were -hemolytic.The present results indicate that there is 
no significant correlation in the hemolytic properties in 
case of hemagglutinating and non-hemagglutinating gram-
negative uropathogens.  
CONCLUSION 
Escherichia coli are the commonest cause of UTI. 
Adherence is one of the essential pre-requisites to establish 
UTI. Majority of UTI in men are mono-microbial. Most of 
uropathogens are susceptible to amikacin (81%) and 
nitrofurantoin (60%). Most of the Gram-negative bacteria 
showed hemagglutinating to both MRHA and MSHA of 
different species of erythrocytes. Maximum adherence 
capability was seen in E. coli (71/ cell) giving both MSHA 
and MRHA. 
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